Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Observed third-party advertiser to IVY RX GLP-1 destination; no official partnership inferred. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A dedicated care page presents a direct offer, care process, product options and supporting information before enrollment. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The story brings in a second buyer: the mom who assumed GLP-1 costs thousands and replies “wait, that's it?” That reaction is the hook, and it fits the persona idea of looking past the user to whoever else is weighing the cost. At 25 seconds it's the tightest version of the price argument in this set, with the same $1,000+ vs $77 overlay and the same five-minute, doctor-reviewed process at the end.
The mom's reaction is the best moment, but we only hear about it; we never see the text or the price she saw. And like its sibling ads, the $77 rests on a 12-month plan shown in small type, and the speaker is an actor portrayal. If you make one like this, show the text message on screen with the price in it, and say the plan terms out loud, so the reaction feels earned and the price holds up on the page.
A family conversation is a familiar way into a price question.
The reaction does the persuading in someone else's voice.
Framing the price as a reason to look closer keeps the claim modest.
The process detail removes the effort objection.
The end card turns the story into a checklist of reasons and a single next step.
GLP-1 for $77 a month, based on a 12-month plan per the on-screen note, against a $1,000+ price elsewhere.
The click goes to IVY RX's GLP-1 landing page, a focused page whose hero repeats the price (“From $77 (4 doses/month)”) with Get Started and Learn More buttons and a 4.7 rating from 7,000+ reviews. The next section, “A low price is easy to find. Exceptional care after checkout isn't,” answers the doubt a cheap price raises. The page doesn't mention the 12-month plan the ad's note refers to, so the two price explanations don't quite meet.
IVY RX's GLP-1 landing page opens on “Stop fighting your metabolism,” a from-$77 price and Get Started, then moves through clinical care and quality, the care process, product and plan options and an enrollment CTA. 4 ads in the Fluid library land here, all actor-portrayal videos from an advertiser called GLP-1 Journey Guide comparing $77 a month to everyday costs.
Leads with “Stop fighting your metabolism. Reset it with GLP-1s,” a from-$77 price, two buttons, a 4.7 rating and badges, answering what it is and what it costs.
Pairs review quotes with four questions every provider should answer, answering whether a low price means worse care.
Explains the steps from the online form to a clinician's review and delivery, answering how getting started works.
Lays out the available options and plans, answering which one fits and what each costs.
Adds supporting details and a final enrollment button, answering the last doubts before starting.
Read the full breakdown of this page
One of 5 IVY RX ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.